Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3.
Hongmei YangChang-Ki OhHaitham AmalJohn S WishnokSarah LewisEmily SchahrerDorit TrudlerTomohiro NakamuraSteven R TannenbaumStuart A LiptonPublished in: Science advances (2022)
Protein S-nitros(yl)ation (SNO) is a posttranslational modification involved in diverse processes in health and disease and can contribute to synaptic damage in Alzheimer's disease (AD). To identify SNO proteins in AD brains, we used triaryl phosphine ( SNO TRAP) combined with mass spectrometry (MS). We detected 1449 SNO proteins with 2809 SNO sites, representing a wide range of S-nitrosylated proteins in 40 postmortem AD and non-AD human brains from patients of both sexes. Integrative protein ranking revealed the top 10 increased SNO proteins, including complement component 3 (C3), p62 (SQSTM1), and phospholipase D3. Increased levels of S-nitrosylated C3 were present in female over male AD brains. Mechanistically, we show that formation of SNO-C3 is dependent on falling β-estradiol levels, leading to increased synaptic phagocytosis and thus synapse loss and consequent cognitive decline. Collectively, we demonstrate robust alterations in the S-nitrosoproteome that contribute to AD pathogenesis in a sex-dependent manner.
Keyphrases
- cognitive decline
- reduced graphene oxide
- perovskite solar cells
- room temperature
- mass spectrometry
- mild cognitive impairment
- gold nanoparticles
- protein protein
- public health
- healthcare
- end stage renal disease
- endothelial cells
- newly diagnosed
- oxidative stress
- amino acid
- binding protein
- ejection fraction
- high resolution
- small molecule
- prognostic factors
- ms ms
- mental health
- health information
- estrogen receptor
- high performance liquid chromatography
- patient reported outcomes